SCHEMBL165846

SCHEMBL165846

CCCC1CCC(c2ccc(-c3ccc(C4CCC(CCC)CC4)cc3F)cc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 5/20 0.49
ALDH1A1 P00352 1/20 0.47
LMNA P02545 1/20 0.47
MAPT P10636 1/20 0.47
MEN1 O00255 1/20 0.47
MAPK1 P28482 1/20 0.47
KMT2A Q03164 1/20 0.47
CYP3A4 P08684 5/20 0.46
APP P05067 2/20 0.43
ESR2 Q92731 8/20 0.42
CYP2D6 P10635 2/20 0.42
CYP2C19 P33261 1/20 0.42
FASN P49327 1/20 0.41
ESR1 P03372 6/20 0.37
DGAT1 O75907 2/20 0.36
SOAT1 P35610 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8831577 1.00 CYP2C9 (0.49) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL19789502 1.00 CYP2C9 (0.49) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL165845 1.00 CYP2C9 (0.49) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL11189619 0.96 CYP2C9 (0.46) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL16546482 0.96 CYP2C9 (0.46) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL11189613 0.96 CYP2C9 (0.46) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL17897885 0.95 CYP2C9 (0.45) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL7910124 0.95 CYP2C9 (0.46) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL7910115 0.95 CYP2C9 (0.46) CYP2C9ALDH1A1LMNAMAPTMEN1
SCHEMBL15868567 0.95 FASN (0.47) CYP2C9ALDH1A1LMNAMAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 448 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3022273-B1 LIQUID CRYSTAL POLYMER COMPOSITION, METHOD FOR PREPARING SAME, AND LIQUID CRYSTAL ARTICLE COMPRISING SAME SAINT GOBAIN (FR) 2018-04-11 EP claimed
EP-3022273-A1 LIQUID CRYSTAL POLYMER COMPOSITION, METHOD FOR PREPARING SAME, AND LIQUID CRYSTAL ARTICLE COMPRISING SAME Saint-Gobain Glass France (FR) 2016-05-25 EP claimed
EP-2915004-A1 VARIABLE LIGHT DIFFUSION SYSTEM COMPRISING A PDLC LAYER Saint-Gobain Glass France (FR) 2015-09-09 EP claimed
WO-2015007218-A1 LIQUID CRYSTAL POLYMER COMPOSITION, METHOD FOR PREPARING SAME, AND LIQUID CRYSTAL ARTICLE COMPRISING SAME SAINT-GOBAIN GLASS FRANCE (FR) 2015-01-22 WO claimed
WO-2014068203-A1 VARIABLE LIGHT DIFFUSION SYSTEM COMPRISING A PDLC LAYER SAINT-GOBAIN GLASS FRANCE (FR) 2014-05-08 WO claimed
US-5279763-A Nematic liquid-crystal composition for active matrix application MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1994-01-18 US claimed
EP-3658980-B2 VEHICLE PANE WITH PDLC FILM WITH DEFINED DROPLET SIZE DISTRIBUTION FOR REDUCING THE CORONA EFFECT SAINT GOBAIN (FR) 2025-03-26 EP disclosed
US-20230287272-A1 LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DEVICE DIC CORPORATION (JP) 2023-09-14 US disclosed
EP-2856256-B1 PROCESS OF PROJECTION OR RE-PROJECTION ON A GLASS COMPRISING A TRANSPARENT LAYERED ELEMENT PRESENTING DIFFUSE REFLECTION PROPERTIES SAINT GOBAIN (FR) 2023-09-06 EP disclosed
US-11739270-B2 Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound DIC CORPORATION (JP) 2023-08-29 US disclosed
CN-109588053-B Vehicle glazing comprising a PDLC film with a specific droplet size distribution for reducing corona effects 法国圣戈班玻璃厂 2023-03-17 CN disclosed
US-11294251-B2 Electrically controllable device having an electroactive layer containing liquid crystals and a polymeric barrier between the electroactive layer and an electrode SAINT-GOBAIN GLASS FRANCE (FR) 2022-04-05 US disclosed
US-11262610-B2 Vehicle window pane with polymer film with defined droplet size distribution SAINT-GOBAIN GLASS FRANCE (FR) 2022-03-01 US disclosed
EP-0158252-A2 Liquid crystal phase MERCK PATENT GmbH (DE) 1985-10-16 EP disclosed
EP-0155317-A1 LIQUID CRYSTAL MIXTURES AND NEW ANISOTROPIC COMPOUNDS THEREFOR. MERCK PATENT GMBH (DE) 1985-09-25 EP disclosed
WO-1985001295-A1 LIQUID CRYSTAL MIXTURES AND NEW ANISOTROPIC COMPOUNDS THEREFOR MERCK Patent Gesellschaft mit beschränkter Haftung (DE) 1985-03-28 WO disclosed
EP-0118061-A2 Liquid crystal guest host systems MERCK PATENT GmbH (DE) 1984-09-12 EP disclosed
EP-0064193-B1 4,4'-BIS-(CYCLOHEXYL)-BIPHENYL DERIVATIVES THAT CONTAIN FLUORINE, DIELECTRICS CONTAINING THEM, AND ELECTRO-OPTICAL INDICATOR ELEMENT MERCK PATENT GmbH (DE) 1984-07-25 EP disclosed
US-4419264-A Fluorine-containing 4,4'-bis-(cyclohexyl)-biphenyl derivatives, and dielectrics and electro-optical display elements containing them MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1983-12-06 US disclosed
EP-0064193-A1 4,4'-Bis-(cyclohexyl)-biphenyl derivatives that contain fluorine, dielectrics containing them, and electro-optical indicator element MERCK PATENT GmbH (DE) 1982-11-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11739270-B2 Polymerizable compound as well as liquid crystal composition and liquid crystal display device each including polymerizable compound OCIAD2, PKN2, SKP1 CYP2C9 3955/4885ALDH1A1 3448/4885LMNA 3654/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.